Answers are grounded in this paper and cite their sources.
Ocular rosacea remains challenging to diagnose and treat, particularly in children (pediatric blepharokeratoconjunctivitis), often leading to delayed intervention and poor outcomes. A multidisciplinary approach, including new therapeutic options, holds promise for improving patient care. Further research into the genetic and molecular basis of ocular rosacea may enable more personalized treatments.
No takes yet. Share an insight, caveat, or question.
Mohamed‐Noriega et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: